Næste

Automatisk afspilning

Managing Avelumab Side Effects in Patients With Merkel Cell Carcinoma

2 Visninger • 07/17/23
Del
Indlejre
administrator
administrator
Abonnenter
0

Howard L. Kaufman, MD, FACS, chief surgical officer and associate director for clinical science at Rutgers Cancer Institute of New Jersey, discusses the adverse event profile of avelumab (Bavencio) for patients with Merkel cell carcinoma.

Vis mere
0 Kommentarer sort Sorter efter
Facebook kommentarer

Næste

Automatisk afspilning